These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 28883730)

  • 41. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
    Hosoya H; Dobroff AS; Driessen WH; Cristini V; Brinker LM; Staquicini FI; Cardó-Vila M; D'Angelo S; Ferrara F; Proneth B; Lin YS; Dunphy DR; Dogra P; Melancon MP; Stafford RJ; Miyazono K; Gelovani JG; Kataoka K; Brinker CJ; Sidman RL; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1877-82. PubMed ID: 26839407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
    Pan J; Feng SS
    Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress in lipid-based nanoparticles for cancer therapy.
    Grinberg S; Linder C; Heldman E
    Crit Rev Oncog; 2014; 19(3-4):247-60. PubMed ID: 25271433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanomedicine applications in the treatment of breast cancer: current state of the art.
    Wu D; Si M; Xue HY; Wong HL
    Int J Nanomedicine; 2017; 12():5879-5892. PubMed ID: 28860754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
    Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
    Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical developments in nanotechnology for cancer therapy.
    Heidel JD; Davis ME
    Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting mitochondrial function for the treatment of breast cancer.
    Deus CM; Coelho AR; Serafim TL; Oliveira PJ
    Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.
    Abedin F; Anwar MR; Asmatulu R; Yang SY
    J Biomater Appl; 2015 Jul; 30(1):38-49. PubMed ID: 25638169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
    Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
    J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M; Kendall J; Denny W; Garg S
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precision arrows: Navigating breast cancer with nanotechnology siRNA.
    Jayaswal N; Srivastava S; Kumar S; Belagodu Sridhar S; Khalid A; Najmi A; Zoghebi K; Alhazmi HA; Mohan S; Tambuwala MM
    Int J Pharm; 2024 Sep; 662():124403. PubMed ID: 38944167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
    Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
    Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
    Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
    Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.